Why we need a clinical trial of hydroxycholoroquine, azithromycin, and zinc ASAP
Excerpt: The "main finding of this study is that after adjusting for the timing of zinc therapy, we found that the addition of zinc sulfate to hydroxychloroquine and azithromycin was found to associate with a decrease in mortality or transition to hospice among patients who did not require ICU level of care, but this association was not significant in patients who were treated in the ICU." (Gilead's drug reportedly likely 30% effective (right up there with this year's flu shot) and $1,000/dose IV hospital only, pushed by Fauci. DTS push to naysay anything Trump says looks promising, inexpensive and works..... Barb)
No comments:
Post a Comment